Sort
40,608 grants matching “prostate cancer”
Light Activation of Enzyme Inhibition
$354,128Jeremy Kodanko · Wayne State University · R01 · FY2015 · EB
First in human study with 18F-avb6-targeting peptide
$354,083Julie L Sutcliffe · University Of California At Davis · R01 · FY2017 · CA
INCORPORATING ELECTRICAL PROPERTY SENSING INTO A CLINICAL BIOPSY NEEDLE FOR ENHANCED PROSTATE CANCER DETECTION
$354,079Trustees Of Dartmouth College · · FY2009 · Department of Defense
Cholesterol and Prostate Health
$354,068Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2013 · DK
SOX9 in prostate cancer development and progression
$354,061Xin Yuan · Beth Israel Deaconess Medical Center · R01 · FY2011 · DK
SOX9 in prostate cancer development and progression
$354,061Xin Yuan · Beth Israel Deaconess Medical Center · R01 · FY2012 · DK
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$354,001Xin Lu · University Of Notre Dame · R01 · FY2022 · CA
NEW AWARD - THE ROLE OF THE PARALOGS CBP AND P300 IN ANDROGEN RECEPTOR FUNCTION AND PROSTATE CANCER...EFFECTIVE 7/1/2020, SIGNED 1/27/2020, DISTRIBUTED 1/28/2020, FAADC 1/28/2020
$354,000Dana-Farber Cancer Institute, Inc. · · FY2020 · Department of the Army
Role of Shh in developmental patterning and proliferation of digit skeleton
$353,987Susan Mackem · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$353,987Xin Lu · University Of Notre Dame · R01 · FY2021 · CA
Nanotechnology enabled targeting of p53 deficiency in human cancer
$353,962Xiaoming He · Univ Of Maryland, College Park · R01 · FY2018 · CA
Project 3: Towards Understanding Prostate Cancer Heterogeneity
$353,910Mark A. Rubin · Weill Medical Coll Of Cornell Univ · P50 · FY2020 · CA
High-potency nitro antimicrobials for topical treatment of trichomoniasis
$353,902David H Peyton · Designmedix, Inc. · R41 · FY2016 · AI
The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker
$353,883Bin He · Methodist Hospital Research Institute · R01 · FY2018 · CA
Multi-phase Microfluidic Devices for Characterization of Circulating Tumor Cells
$353,872John Zhong · University Of Southern California · R01 · FY2012 · CA
Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer
$353,866Wenliang Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · CA
Focused Genomic Dissection of the Prostate Cancer Risk Variant on Chromosome 8q24
$353,816Kari Stefansson · Decode Genetics, Inc. · R01 · FY2007 · CA
Genetics and Biology of Metastatic Colorectal Cancer
$353,811Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Targeting allosteric scaffolding functions of Aurora kinase A in cancer
$353,800Nicholas Mark Levinson · University Of Minnesota · R01 · FY2021 · CA
TMPRSS2-ERG chromosomal translocations and prostate cancer
$353,789Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling
$353,772Hancai Dan · University Of Maryland Baltimore · R01 · FY2018 · CA
Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling
$353,772Hancai Dan · University Of Maryland Baltimore · R01 · FY2021 · CA
Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling
$353,772Hancai Dan · University Of Maryland Baltimore · R01 · FY2020 · CA
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$353,762Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2019 · CA
Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF
$353,760Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA